Home > Media & Technology > Next Generation Technologies > AI and Machine Learning > AI in Predictive Toxicology Market

AI in Predictive Toxicology Market Share

Report ID: GMI7363
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

AI in Predictive Toxicology Market Share

Major companies operating in the AI in predictive toxicology industry are:

Benevolent AI
Berg Health
Biovista
Celsius Therapeutics
Chemaxon Ltd.
Cyclica
Exscientia PLC
Insilico Medicine
Instem plc
Lhasa Limited
Recursion Pharmaceuticals

Major companies in the AI in predictive toxicology market are fiercely competing for a share through substantial investments in R&D along with technological advancements. This strategy is aimed at developing cutting-edge solutions, stay ahead in innovations, and capture a significant share of the rapidly evolving predictive toxicology market.

Authors: Preeti Wadhwani

Frequently Asked Questions (FAQ) :

The market size of AI in predictive toxicology reached USD 281 million in 2022 and is set to expand at over 29.5% CAGR from 2023 to 2032, attributed to the increasing investments in pharmaceutical AI startups.

The solution segment accounted for more than 70% of the market share in 2022, owing to the ongoing development of advanced precision medicine and treatment solutions.

North America held more than 44% of the market share in 2022, driven by the robust presence of the pharmaceutical sector in the region.

Some of the leading companies engaged in industry are Benevolent AI, Berg Health, Celsius Therapeutics, Chemaxon Ltd., Insilico Medicine, Instem plc, Lhasa Limited, and, Recursion Pharmaceuticals.